Below are the most recent publications written about "Vasodilation" by people in Profiles.
-
Witkowski S, Tha Ra Wun T, Brunzelle J, Buszkiewicz S, Murphy L, Garcia RL, Sievert LL. Higher amounts of habitual physical activity changes the relationship between hot flashes and subclinical cardiovascular disease risk. Physiol Rep. 2025 Feb; 13(3):e70248.
-
Kapoor A, Yew B, Jang JY, Dutt S, Li Y, Alitin JPM, Gaubert A, Ho JK, Blanken AE, Sible IJ, Marshall A, Shao X, Mather M, Wang DJJ, Nation DA. Older adults with perivascular spaces exhibit cerebrovascular reactivity deficits. Neuroimage. 2022 12 01; 264:119746.
-
Dillon GA, Stanhewicz AE, Serviente C, Flores VA, Stachenfeld N, Alexander LM. Seven days of statin treatment improves nitric-oxide mediated endothelial-dependent cutaneous microvascular function in women with endometriosis. Microvasc Res. 2022 11; 144:104421.
-
Dillon GA, Stanhewicz AE, Serviente C, Greaney JL, Alexander LM. Hydrogen sulfide-dependent microvascular vasodilation is improved following chronic sulfhydryl-donating antihypertensive pharmacotherapy in adults with hypertension. Am J Physiol Heart Circ Physiol. 2021 10 01; 321(4):H728-H734.
-
Serviente C, Berry CW, Kenney WL, Alexander LM. Healthy active older adults have enhanced K+ channel-dependent endothelial vasodilatory mechanisms. Am J Physiol Regul Integr Comp Physiol. 2020 07 01; 319(1):R19-R25.
-
Patel AB, Verma A. COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence? JAMA. 2020 May 12; 323(18):1769-1770.
-
Serviente C, Witkowski S. Follicle-stimulating hormone, but not cardiorespiratory fitness, is associated with flow-mediated dilation with advancing menopausal stage. Menopause. 2019 05; 26(5):531-539.
-
Jansen T, Kröller-Schön S, Schönfelder T, Foretz M, Viollet B, Daiber A, Oelze M, Brandt M, Steven S, Kvandová M, Kalinovic S, Lagrange J, Keaney JF, Münzel T, Wenzel P, Schulz E. ?1AMPK deletion in myelomonocytic cells induces a pro-inflammatory phenotype and enhances angiotensin II-induced vascular dysfunction. Cardiovasc Res. 2018 12 01; 114(14):1883-1893.
-
Reynolds JD, Jenkins T, Matto F, Nazemian R, Farhan O, Morris N, Longphre JM, Hess DT, Moon RE, Piantadosi CA, Stamler JS. Pharmacologic Targeting of Red Blood Cells to Improve Tissue Oxygenation. Clin Pharmacol Ther. 2018 09; 104(3):553-563.
-
Kruse MJ, Kovell L, Kasper EK, Pomper MG, Moller DR, Solnes L, Chen ES, Schindler TH. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2017 02; 10(2):157-167.